skip to main content
Idioma:
Resultados 1 2 3 next page
Mostrar Somente
Refinado por: idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Genotyping of UGT1A1 and DPYD polymorphisms in patients with colorectal cancer. A review
Genotyping of UGT1A1 and DPYD polymorphisms in patients with colorectal cancer. A review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genotyping of UGT1A1 and DPYD polymorphisms in patients with colorectal cancer. A review

Timoshkina, Natalia N. ; Petrusenko, Natalia A. ; Gabrichidze, Petr N. ; Cherkess, Maria A. ; Pushkareva, Tatiana F. ; Savchenko, Dmitry A.

Sovremennaia onkologiia : zhurnal kafedry onkologii RMAPO dlia nepreryvnogo poslediplomnogo obrazovaniia, 2024-02, Vol.25 (4), p.447-453 [Periódico revisado por pares]

IP Habib O.N

Texto completo disponível

Citações Citado por
2
Analysis of prognostic factors for survival in the Russian population of patients with disseminated gastric cancer, who received ramucirumab as secondline therapy in the RAMSELGA trial
Analysis of prognostic factors for survival in the Russian population of patients with disseminated gastric cancer, who received ramucirumab as secondline therapy in the RAMSELGA trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Analysis of prognostic factors for survival in the Russian population of patients with disseminated gastric cancer, who received ramucirumab as secondline therapy in the RAMSELGA trial

Besova, N. S. ; Titova, T. A. ; Artamonova, Е. V. ; Tryakin, A. A. ; Stroyakovskiy, D. L. ; Perminova, E. V. ; Yukalchuk, D. Yu ; Ponomarenko, D. M. ; Belyak, N. P. ; Orlova, R. V. ; Teletaeva, G. M. ; Ratner, E. Yu ; Mochalova, A. S. ; Gordeeva, O. O. ; Zhabina, A. S. ; Gamayunov, S. V. ; Smolin, A. V. ; Povyshev, A. Yu ; Andrievskikh, M. I. ; Stilidi, I. S.

Medicinskij sovet, 2020-07 (9), p.165-174 [Periódico revisado por pares]

Remedium Group LLC

Texto completo disponível

Citações Citado por
3
A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease
A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease

Zatloukal, P. ; Cardenal, F. ; Szczesna, A. ; Gorbunova, V. ; Moiseyenko, V. ; Zhang, X. ; Cisar, L. ; Soria, J.-C. ; Domine, M. ; Thomas, M.

Annals of oncology, 2010-09, Vol.21 (9), p.1810-1816 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Tolerance of ramucirumab in the second-line therapy of patients with disseminated gastric cancer in the routine clinical practice of Russia
Tolerance of ramucirumab in the second-line therapy of patients with disseminated gastric cancer in the routine clinical practice of Russia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tolerance of ramucirumab in the second-line therapy of patients with disseminated gastric cancer in the routine clinical practice of Russia

Besova, N. S. ; Titova, T. A. ; Artamonova, E. V. ; Stroyakovskiy, D. L. ; Perminova, E. V. ; Yukal’chuk, D. Yu ; Ponomarenko, D. M. ; Belyak, N. P. ; Orlova, R. V. ; Teletaeva, G. M. ; Ratner, E. Yu ; Mochalova, A. S. ; Gordeeva, O. O. ; Zhabina, A. S. ; Gamayunov, S. V. ; Smolin, A. V. ; Povyshev, A. Yu ; Andrievskikh, M. I. ; Tryakin, A. A. ; Stilidi, I. S.

Medicinskij sovet, 2019-12 (19), p.104-113 [Periódico revisado por pares]

Remedium Group LLC

Texto completo disponível

Citações Citado por
5
Results of using 3-component regimen TEGOXIRI (tegafur, oxaliplatin, irinotecan) ± Leucovorin in patients with advanced colorectal cancer
Results of using 3-component regimen TEGOXIRI (tegafur, oxaliplatin, irinotecan) ± Leucovorin in patients with advanced colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Results of using 3-component regimen TEGOXIRI (tegafur, oxaliplatin, irinotecan) ± Leucovorin in patients with advanced colorectal cancer

Dobrova, N. V. ; Darenskaya, A. D.

Medicinskij sovet, 2019-12 (19), p.92-102 [Periódico revisado por pares]

Remedium Group LLC

Texto completo disponível

Citações Citado por
6
Results of the use of ramucirumab in combination with irinotecan and fluoropyrimidines in the second-line chemotherapy for disseminated gastric cancer
Results of the use of ramucirumab in combination with irinotecan and fluoropyrimidines in the second-line chemotherapy for disseminated gastric cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Results of the use of ramucirumab in combination with irinotecan and fluoropyrimidines in the second-line chemotherapy for disseminated gastric cancer

Besova, N. S. ; Titova, T. A. ; Stroyakovsky, D. L. ; Perminova, E. V. ; Bagrova, S. G. ; Obarevich, E. S. ; Gorbunova, V. A. ; Artamonova, E. V. ; Stilidi, I. S.

Medicinskij sovet, 2019-06 (10), p.100-109 [Periódico revisado por pares]

Remedium Group LLC

Texto completo disponível

Citações Citado por
7
Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting
Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting

N. S. Besova ; Т. А. Titova ; А. А. Tryakin ; Е. V. Artamonova ; Е. S. Obarevich ; D. L. Stroyakovskiy ; О. Е. Kalinin ; I. S. Stilidi

Medicinskij sovet, 2021-06 (4S), p.64-78 [Periódico revisado por pares]

Remedium Group LLC

Texto completo disponível

Citações Citado por
8
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

Cohn, A.L. ; Tabernero, J. ; Maurel, J. ; Nowara, E. ; Sastre, J. ; Chuah, B.Y.S. ; Kopp, M.V. ; Sakaeva, D.D. ; Mitchell, E.P. ; Dubey, S. ; Suzuki, S. ; Hei, Y.-J. ; Galimi, F. ; McCaffery, I. ; Pan, Y. ; Loberg, R. ; Cottrell, S. ; Choo, S.-P.

Annals of oncology, 2013-07, Vol.24 (7), p.1777-1785 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Results of using tegafur in combination with irinotecan and oxaliplatin in patients with advanced colorectal cancer
Results of using tegafur in combination with irinotecan and oxaliplatin in patients with advanced colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Results of using tegafur in combination with irinotecan and oxaliplatin in patients with advanced colorectal cancer

N. V. Dobrova ; E. I. Borisova ; A. D. Darenskaya

Medicinskij sovet, 2018-11 (19), p.42-49 [Periódico revisado por pares]

Remedium Group LLC

Texto completo disponível

Citações Citado por
10
CHEMOTHERAPY IN THE MANAGEMENT OF LOCALIZED AND METASTATIC COLON CANCER: NEW AND YET UNFORGOTTEN APPROACHES
CHEMOTHERAPY IN THE MANAGEMENT OF LOCALIZED AND METASTATIC COLON CANCER: NEW AND YET UNFORGOTTEN APPROACHES
Material Type:
Artigo 		Adicionar ao Meu Espaço

CHEMOTHERAPY IN THE MANAGEMENT OF LOCALIZED AND METASTATIC COLON CANCER: NEW AND YET UNFORGOTTEN APPROACHES

Dobrova, N. V. ; Gordeeva, O. O. ; Chernoglazova, E. V. ; Tryakin, A. A.

Medicinskij sovet, 2017-11 (14), p.67-76 [Periódico revisado por pares]

Remedium Group LLC

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (17)

Data de Publicação 

De até
Refinar
  1. Antes de2004  (2)
  2. 2004Até2009  (3)
  3. 2010Até2014  (2)
  4. 2015Até2018  (7)
  5. Após 2018  (8)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.